TY  - CHAP
M1  - Book, Section
TI  - #VisualAbstract Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)
A1  - Lau, Kathleen
Y1  - 2015
N1  - 
T2  - 2 Minute Medicine
AB  - 
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2021/02/26
UR  - accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=555153
ER  -